EGFR and lung cancer: Detection of EGFR mutation in plasma-derived ctDNA from patients with lung cancers represents an interesting alternative to EGFR genetic analyses in patients that cannot undergo tissue biopsy due to their advanced disease and/ or poor performance status, and in cases of insufficient material obtained from tissue biopsies.